SLC34A3 and hypophosphatemia: Increased renal phosphate wasting, mild hypophosphatemia, increased 1,25(OH)2D and hypercalciuria without metabolic bone disease, can be present in patients with heterozygous SLC34A3 mutations, indicating haploinsufficiency (124).